The cost of drugs in the U.S. continues to skyrocket. The average drug price increase from 2022 to 2023 was 15%, according to the United States Department of Health and Human Services. Some federal ...
After being called out on some intellectual property claims late last year, Teva has fallen victim to the Federal Trade ...
In a bid to prevent the patent system from being abused, the U.S. Patent and Trademark Office has proposed a new rule ...
The decision comes after the FTC's warnings to drugmakers over the misuse of Orange Book patent listings to wrongly extend ...
The cost of drugs in the U.S. continues to skyrocket. The average drug price increase from 2022 to 2023 was 15%, according to the United States Department of Health and Human Services. Some federal ...
Drugmaker Amneal Pharmaceuticals with the backing of the U.S. Federal Trade Commission convinced a New Jersey federal court ...
The cost of drugs in the U.S. continues to skyrocket. The average drug price increase from 2022 to 2023 was 15%, according to the United States Department of Health and Human Services.